About Nico Neuro
Nico Neuro is a Healthcare company based in Indianapolis (United States) founded in 2007, and was acquired by Stryker in September 2024. Technology for neurological corridor surgery is developed by NICO. Nico Neuro has raised $58.6 million across 6 funding rounds from investors including Stryker, Square 1 Bank and Indiana University Health. Nico Neuro offers products and services including NICO Myriad SPECTRA and BrainPath. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is NICO ApS. Its competitors include Zeta Surgical, Q’Apel Medical and CalmiGo; 2 of its 3 listed competitors have raised funding.
Company details
NICO was founded in 2007 in Indianapolis, United States, within the medical technology sector focused on neurosurgery. Access through smaller openings for brain lesions is enabled by products such as BrainPath, while soft tissue abnormalities are resected using the Myriad handpieces console system. Fluid management is handled by the TRIOwand wand, supporting minimally invasive procedures in neurological surgery.
- Headquarters Indianapolis, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website niconeuro.com
- Social LinkedIn X YouTube
- Acquired by Stryker (Sep 2024)
- Legal Name Nico Aps
Products & Services of Nico Neuro
Nico Neuro offers a comprehensive portfolio of products and services, including NICO Myriad SPECTRA and BrainPath.
Hand-held device for fluorescence-guided surgery with multiple capabilities.
Tool for minimally invasive access in neurosurgery procedures.
Apps and channels of Nico Neuro
its YouTube channel NICO Corporation has 547 subscribers and 30 videos.
Videos from Nico Neuro
The most watched videos on Nico Neuro's YouTube channel, NICO Corporation (547 subscribers). Click a video to play it here.
More on NICO Corporation.
Funding Insights of Nico Neuro
Nico Neuro has successfully raised a total of $58.6M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $12.59 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $58.6M
- Total Rounds 6
- Last Round Series B — $12.59M
- First Round $11.93M
(Jul 2009)
- Investors Count 6
All 6 funding rounds of Nico Neuro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $12.59M | Series B | – | – | |
| Nov 2018 | $12.51M | Series B | – | – | – |
| Jun 2016 | $8M | Debt – Conventional | – | – | |
| Feb 2016 | $15M | Series B | – | – | |
| Jul 2012 | $6.57M | Series A | – | – | |
| Jul 2009 | $11.93M | Series A | – | Twilight Venture Partners, Rose-Hulman | – |
7 investors in total: 7 institutional.
Investors in Nico Neuro
Nico Neuro has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, Square 1 Bank and Indiana University Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| rccf.com | ||||
Early-stage life science companies are supported through venture capital. | twivp.com | Indianapolis, United States | ||
Venture debt, treasury, and cash management services are provided. | 2005 | square1bank.com | Durham, United States | |
Multiple courses and degrees are offered across diversified academic streams. | 1874 | rose-hulman.edu | United States | |
Healthcare services are delivered through hospitals in Indiana. | 1997 | iuhealth.org | Indianapolis, United States | |
Branding and marketing communications services are offered to diverse industries. | 1994 | thehalogroup.com | New York, United States | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | stryker.com | Kalamazoo, United States |
Investor details for Nico Neuro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nico Neuro
17 people are tracked at Nico Neuro (10 in leadership, 6 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Trisha Baumgardt | Product Marketing Director, Tumor | Leadership |
Lorenzo Burrus | Eastern Region Sales Director | Leadership |
Jay Dittman | VP, Operations | Leadership |
Joe Mark | Chief Technology Officer | Leadership |
Jeff Hanthorn | Chief Operating Officer | Leadership |
Jim Pearson | President & CEO | Leadership |
Paul Sandefer | VP, Clinical | Leadership |
Craig Blanchard | VP, Marketing & Field Clinical | Leadership |
Inder Jarial | Engineering Director | Leadership |
Tim Davis | VP, Sales | Leadership |
Mark L. Rosenblum | Board Member | Board & advisors |
Eric B. Timko | Board Member | Board & advisors |
J. Carter Mcnabb | Chairman | Board & advisors |
Thomas M. Tefft | Board Member | Board & advisors |
Brian Gustafson | Board Member | Board & advisors |
Joshua L. Christie | Board Member | Board & advisors |
Tyler Les | Account Development Specialist | Team |
Complete people profiles for Nico Neuro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nico Neuro
4 dated milestones of Nico Neuro across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Nico Neuro is founded.
- Funding First funding round of $11.9M.
- Funding Latest funding round, Series B, of $12.6M.
- Exit Acquired by Stryker.
Competitors of Nico Neuro
Nico Neuro has 3 listed competitors in our database, 2 of them funded. They include Zeta Surgical, Q’Apel Medical and CalmiGo.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zetasurgical.com | 2016 | Boston, United States | $8.16M | 7 | AI-based navigation and robotics systems for surgeries are developed. | |
| qapelmedical.com | 2019 | Fremont, United States | $51.9M | 100 | Medical devices for neurovascular disorder treatments are provided. | |
| calmigo.com | 2010 | New York, United States | Stress-relief devices are developed using smart breathing regulation technology. |
Detailed competitors of Nico Neuro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nico Neuro
The website of Nico Neuro (niconeuro.com) receives about 5.9K visits a month.
- Monthly visits5.9K
▲ 120.7% vs previous month
Top companies in Neurology
3 companies that operate in the same segment as Nico Neuro (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nico Neuro
Complete news archive for Nico Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nico Neuro
Nico Neuro was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Nico Neuro is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Nico Neuro is a funded company, having raised a total of $58.6M across 6 funding rounds to date. The company's 1st funding round was a Series A of $11.93M, raised on Jul 2009.
NICO was founded in 2007 in Indianapolis, United States, within the medical technology sector focused on neurosurgery. Access through smaller openings for brain lesions is enabled by products such as BrainPath, while soft tissue abnormalities are resected using the Myriad handpieces console system. Fluid management is handled by the TRIOwand wand, supporting minimally invasive procedures in neurological surgery.
Nico Neuro's top competitors include Zeta Surgical, Q’Apel Medical and CalmiGo.
Nico Neuro offers NICO Myriad SPECTRA and BrainPath.
Nico Neuro has 7 investors. Key investors include Stryker, Square 1 Bank, Indiana University Health, The Halo Group, and Rose-Hulman.
Nico Neuro operates through Nico Aps.
Yes. Nico Neuro was acquired by Stryker in September 2024.